Literature DB >> 9137930

Prolongation of QTc interval in patients with Parkinson's disease.

H Oka1, S Mochio, H Sato, K Katayama.   

Abstract

QTc intervals were measured in 30 patients with Parkinson's disease and 30 healthy control subjects. The mean value of QTc intervals in patients with Parkinson's disease significantly exceeded that of healthy controls (418 +/- 14 ms vs. 403 +/- 18 ms). Prolongation of the QTc interval was unrelated to the administration of levodopa. The mean QTc interval in patients whose Hoehn and Yahr score was III or more was significantly greater than that of patients whose score was II or less (424 +/- 12 ms vs. 410 +/- 12 ms). A significant correlation between the QTc interval and the Valsalva ratio, as well as the overshoot, was identified. The QTc interval is closely related to autonomic nervous system dysfunction, including abnormal baroreceptor reflex function, in patients with Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9137930     DOI: 10.1159/000117432

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  12 in total

1.  Olfactory dysfunction and cardiovascular dysautonomia in Parkinson's disease.

Authors:  Hisayoshi Oka; Chizuko Toyoda; Makiko Yogo; Soichiro Mochio
Journal:  J Neurol       Date:  2010-01-30       Impact factor: 4.849

Review 2.  Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.

Authors:  Rashmi R Shah
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

3.  Autonomic and electrocardiographic findings in Parkinson's disease.

Authors:  Christopher H Gibbons; David K Simon; Meilin Huang; Barbara Tilley; Michael J Aminoff; Jacquelyn L Bainbridge; Matthew Brodsky; Roy Freeman; John Goudreau; Robert W Hamill; Sheng T Luo; Carlos Singer; Aleksandar Videnovic; Ivan Bodis-Wollner; Pei S Wong
Journal:  Auton Neurosci       Date:  2017-04-14       Impact factor: 3.145

Review 4.  Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Authors:  Valerie Joers; Marina E Emborg
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

Review 5.  Antipsychotic agents and QT changes.

Authors:  R Welch; P Chue
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

6.  Pergolide block of the cloned Kv1.5 potassium channels.

Authors:  Imju Jeong; Bok Hee Choi; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-05       Impact factor: 3.000

7.  Electrocardiogram Characteristics of Different Motor Types of Parkinson's Disease.

Authors:  Ling-Ling Zhong; Ya-Qi Song; Ke-Ju Ju; Ai-Nian Chen; Hua Cao
Journal:  Int J Gen Med       Date:  2021-03-25

8.  Cardiac and Autonomic Dysfunctions Assessed Through Recurrence Quantitative Analysis of Electrocardiogram Signals and an Application to the 6-Hydroxydopamine Parkinson's Disease Animal Model.

Authors:  Lucas Shinoda; Laís Damasceno; Leandro Freitas; Ruy Campos; Sergio Cravo; Carla A Scorza; Fúlvio A Scorza; Jean Faber
Journal:  Front Physiol       Date:  2021-11-24       Impact factor: 4.566

9.  Clinical features and electrocardiogram parameters in Parkinson's disease.

Authors:  Hitoshi Mochizuki; Nobuyuki Ishii; Kazutaka Shiomi; Masamitsu Nakazato
Journal:  Neurol Int       Date:  2017-12-11

10.  Prevalence of QTc Prolongation in Patients with Parkinson's Disease. Assessment of the Effects of Drugs, Clinical Risk Factors and Used Correction Formula.

Authors:  Jakub J Malkiewicz; Maciej Malkiewicz; Joanna Siuda
Journal:  J Clin Med       Date:  2021-03-31       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.